Qualigen therapeutics, inc. reports year-end 2021 financial results

Carlsbad, calif., april 01, 2022 (globe newswire) -- qualigen therapeutics, inc. (nasdaq: qlgn), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for orphan drug designation, while also commercializing diagnostics, today announces its financial results for the fiscal year ended december 31, 2021.
QLGN Ratings Summary
QLGN Quant Ranking